Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys TRANSCRIPT
Download PDFJan 30, 2025
Kathy Lee-Sepsick, President, Founder, and CEO of Femasys, uses innovative medical technologies to address unmet women's reproductive healthcare needs. Femasyis is developing treatments for infertility and birth control and diagnostic tools to support its treatment offerings. The devices are intentionally designed to be more accessible, less invasive, and safer for women than existing options, some of which have not changed in 100 years.
Kathy explains, "Our technologies are just for women. So, we include broad categories of women. And we did this, particularly with the FemBloc product that we're advancing. It's a non-surgical permanent birth control solution for women that is delivered in the office. No anesthesia, no incisions, no hormones, no implants, none of the things that come par for the course for what's out there right now. And we included in our patient population women who did not have children before, which had never been done before."
"So, there've been other technologies that have come and have failed in this market in an attempt to bring forward a permanent birth control solution that's non-surgical. And they only included women who have had children. When you include women who haven't had children, you have to be very responsible to do that because women should have a choice no matter what their choice is as far as childbearing."
"When we think about infertility, it's not just a woman’s issue. And we're seeing the problems in donor sperm also, whether it's a single person or the LGTQ community that's coming forward, they have to get the sperm to contribute to the overall process. And the sperms compromised, like I said, even with donors. So we see a third of the time that it's strictly the male issue. About a third of the time, it's a female issue only, and then the combination is both. So about 50% of the time the male factor is contributing."
#Femasys $FEMY #WomensHealth #IVF #Fertility #Birthcontrol #FemaSeed #FemBloc #FemVue #FemCerv
